Global Animal Model Market to Reach USD 3,151 Million by 2033, Propelled by Rising Demand for Effective Therapies

December 27, 2024 | Healthcare

According to the latest report by IMARC Group, titled “Animal Model Market Report by Animal Type (Rat, Mice, Guinea Pigs, Rabbits, and Others), Technology (CRISPR, Embryonic Stem Cell Injection, Nuclear Transfer, and Others), Application (Drug Discovery and Development, Basic Research, and Others), End User (Pharma and Biotech Companies, Academic Research Institutes, and Others), and Region 2025-2033," the global animal model market size reached USD 1,916 Million in 2024. Animal models refer to the non-human species used in biomedical research to mimic the aspects of biological processes and diseases found in humans. They include rats, mice, zebrafish, rabbits, monkeys, dogs, hamsters, and pigs. They are widely used for studying disease mechanisms, drug discovery and development, preclinical testing, drug screening, target validation, pharmacokinetics studies, biomarker identification, and genetic studies. Animal models aid in evaluating the safety and efficacy of vaccines, identifying factors that influence drug metabolism, and assessing potential side effects of the drug delivery systems. They also assist researchers in optimizing clinical trials, gaining deeper insights into disease progression, refining treatment regimes, and assessing the optimal dosage quantity.

Global Animal Model Market Trends:

The rising demand for effective therapies across the globe is one of the primary factors propelling the market growth. Animal models are widely used to assess the safety, efficacy, and toxicity of drug candidates, determine safe dosage ranges, optimize formulations, identify best administration routes, and minimize the risk of adverse side effects in human subjects. Furthermore, the growing prevalence of chronic conditions, such as cancer, neurological disorders, acute infections, and cardiovascular diseases (CVDs), is facilitating the demand for animal models to understand disease mechanisms, identify drug targets, and assess the efficacy of potential treatment options. Additionally, the utilization of advanced gene editing tools, such as clustered regularly interspaced short palindromic repeats (CRISPR-Cas9), to create animal models with precise genetic modifications to study human genetic diseases and identify the underlying mechanism is positively influencing the market growth. Besides this, the recent development of humanized animal models by introducing human genes, tissues, and immune cells into animals to study human-specific diseases and test the efficacies of various therapeutics is contributing to the market growth. Moreover, the implementation of strict government regulations to mandate preclinical testing using animal models to ensure drug safety and efficacy is supporting the market growth. Other factors, including growing demand for personalized medicines, extensive research and development (R&D) activities, and significant growth in the pharmaceutical industry, are anticipated to drive the market growth. Looking forward, the market value is projected to reach USD 3,151 Million by 2033, expanding at a CAGR of 5.7% during 2025-2033.

Market Summary:

  • On the basis of the animal type, the market has been divided into rat, mice, guinea pig, rabbits, and others.
  • Based on the technology, the market has been classified into CRISPR, embryonic stem cell injection, nuclear transfer, and others.
  • On the basis of the application, the market has been divided into drug discovery and development, basic research, and others.
  • Based on the end user, the market has been classified into pharma and biotech companies, academic research institutes, and others.
  • On a regional basis, the market has been categorized into North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa.
  • The competitive landscape of the industry has also been examined, with some of the key players being Biocytogen, Charles River Laboratories International Inc, Envigo, Eurofins Scientific SE, GenOway S.A., Hera BioLabs, JSR Corporation, Ozgene Pty Ltd., PerkinElmer Inc., Taconic Biosciences Inc., The Jackson Laboratory and Trans Genic Inc.


Report Scope:

Report Features Details
Base Year of the Analysis 2024
Historical Period 2019-2024
Forecast Period 2025-2033
Units Million USD
Segment Coverage Animal Type, Technology, Application, End User, Region
Region Covered Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered Biocytogen, Charles River Laboratories International Inc, Envigo, Eurofins Scientific SE, GenOway S.A., Hera BioLabs, JSR Corporation, Ozgene Pty Ltd., PerkinElmer Inc., Taconic Biosciences Inc., The Jackson Laboratory and Trans Genic Inc.
Customization Scope 10% Free Customization
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)


About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.


Contact Us:

IMARC Group
134 N 4th St.
Brooklyn, NY 11249, USA
Email: Sales@imarcgroup.com
Americas:- +1 631 791 1145 | Africa and Europe :- +44-753-713-2163 | Asia: +91-120-433-0800

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Global Animal Model Market to Reach USD 3,151 Million by 2033, Propelled by Rising Demand for Effective Therapies
Purchase Options New Year Sale
Benefits of Customization
  • Personalize this research
  • Triangulate with your data
  • Get data as per your format and definition
  • Gain a deeper dive into a specific application, geography, customer, or competitor
  • Any level of personalization

Get in Touch With Us

UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials